T&L Co. Ltd Market Cap ($259.96 Million)
Market Cap & Net Worth: T&L Co. Ltd (340570)
T&L Co. Ltd market cap. T&L Co. Ltd (KQ:340570) has a market capitalization of $259.96 Million (₩383.60 Billion) as of November 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #15248 globally and #510 in its home market, demonstrating a -1.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying T&L Co. Ltd's stock price ₩24150.00 by its total outstanding shares 15884240 (15.88 Million). Also see T&L Co. Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
T&L Co. Ltd Market Cap History (2020–2026)
T&L Co. Ltd market cap history from 2020 to 2026. Data shows change from $222.43 Million to $259.96 Million (-1.12% CAGR). Check 340570 stock price for real-time trading data and today's change.
Index Memberships
T&L Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$211.91 Billion | 0.12% | #162 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$211.91 Billion | 0.12% | #162 of 1384 |
Weight: T&L Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
T&L Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how T&L Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 340570 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
T&L Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
T&L Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $222.43 Million | $40.63 Billion | $10.04 Billion | 0.01x | 0.02x |
| 2021 | $496.13 Million | $71.90 Billion | $19.58 Billion | 0.01x | 0.03x |
| 2022 | $384.41 Million | $81.58 Billion | $21.12 Billion | 0.00x | 0.02x |
| 2023 | $430.58 Million | $115.46 Billion | $27.44 Billion | 0.00x | 0.02x |
| 2024 | $720.15 Million | $174.89 Billion | $46.41 Billion | 0.00x | 0.02x |
| 2025 | $528.00 Million | $164.16 Billion | $38.07 Billion | 0.00x | 0.01x |
Competitor Companies of 340570 by Market Capitalization
Companies near T&L Co. Ltd in the global market cap rankings as of November 3, 2026. Also see total assets of T&L Co. Ltd for a full breakdown of the balance sheet.
Key companies related to T&L Co. Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of T&L Co. Ltd (2020–2026)
Market capitalization of T&L Co. Ltd from 2020 to today. Between 2020 and today, T&L Co. Ltd's market cap moved from $222.43 Million to $ 259.96 Million, with a yearly change of -1.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩259.96 Million | -50.76% |
| 2025 | ₩528.00 Million | -26.68% |
| 2024 | ₩720.15 Million | +67.25% |
| 2023 | ₩430.58 Million | +12.01% |
| 2022 | ₩384.41 Million | -22.52% |
| 2021 | ₩496.13 Million | +123.05% |
| 2020 | ₩222.43 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of T&L Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $259.96 Million USD |
| MoneyControl | $259.96 Million USD |
| MarketWatch | $259.96 Million USD |
| marketcap.company | $259.96 Million USD |
| Reuters | $259.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more